MDMG.L Regulatory News (MDMG)

MD Medical Group Holds Investor Day 2014

30 October 2014, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, will today host an Investor Day and site visit for the investment community and sell-side analysts. At the event, MDMG senior management will provide investors and analysts with an update on the Company's strategy and future objectives as a leading private healthcare provider in Russia. No new material information will be disclosed.

The day will include presentations by the management team and site visits to MDMG's hospitals in Moscow: Perinatal Medical Centre (PMC) and Lapino Hospital.

The presentation team will include:

· Dr. Mark Kurtser, Chairman of the Board of Directors

· Dr. Elena Mladova, Chief Executive Officer

· Vitaly Ustimenko, Chief Financial Officer

· Elena Opanasyuk, Deputy CEO for regional expansion

· Yulia Kutakova, Chief Medical Officer

· Larisa Tkachenko, Head of Client service department

The presentation from the event will be available to download from the Company's website at Investors' section.

For further information please contact:

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 21 modern healthcare facilities, including 3 hospitals in Moscow (Perinatal Medical Center (PMC) and Lapino hospital) and Novosibirsk, and 18 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Yaroslavl and Novosibirsk. In addition, the company operates 3 franchised outpatient clinics operate in Kyiv, Ukraine, and its third hospital, in Ufa, is scheduled to open on 31 October 2014. A new outpatient clinic, in Ryazan, is expected to open in Q1 2015.

In 9M 2014, there were 3,287 deliveries in PMC and Lapino. The number of outpatient treatments for 9M 2014 in the Company's clinics totalled 573,872.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.